Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Chuandong Sun is a leading authority in the field of robotic hepatopancreatobiliary (HPB) surgery, with a career dedicated to defining the standards for minimally invasive liver and pancreatic procedures. His major contributions include spearheading two landmark international consensus statements on robotic hepatectomy (2018 and 2023), which have collectively garnered over 300 citations and serve as the global benchmark for safety, feasibility, and efficacy in robotic liver surgery. Dr. Sun also leads high-impact clinical trials, such as the PORTAL trial—a multicenter phase III non-inferiority randomized controlled study comparing robotic versus open pancreatoduodenectomy—which has already attracted significant attention with 44 citations. Further advancing the field, he developed and validated the first novel difficulty scoring system for da Vinci robotic pancreatoduodenectomy, a tool critical for surgical training and patient stratification. With his work cited over 350 times, Dr. Sun’s research not only resolves long-standing controversies regarding cost-effectiveness and technical challenges but also provides the evidence base that guides surgeons worldwide in adopting robotic HPB techniques.